Elsevier Inc.

SHERPA: Unknown

People

  1. Giralt
    Giralt
  2. Perales
    Perales
  3. Van Den Brink
    Van Den Brink
  4. Ponce
    Ponce
  5. Papadopoulos
    Papadopoulos
  6. Young
    Young
  7. Castro-Malaspina
    Castro-Malaspina
  8. Jakubowski
    Jakubowski
  9. Devlin
    Devlin
  10. O'Reilly
    O'Reilly

Groups

  1. Bone Marrow Transplant (52)
  2. Center for Hematologic Malignancies (52)
  3. Department of Medicine (52)
  4. Executive Committee, Center for Hematologic Malignancies (52)
  5. GSK Faculty (52)
  6. Hematologic Malignancies, Division of (52)
  7. Immunology Program Faculty (49)
  8. Sloan Kettering Institute Faculty (49)
  9. CTCR Scholars (42)
  10. Survivorship Research (38)
Search Within
  1. "Center for Hematologic Malignancies"
  2. "Executive Committee, Center for Hematologic Malignancies"
  3. "Sergio Giralt"
Formats
  1. Meeting Abstract (39)
  2. Journal Article (13)
Groups
  1. Bone Marrow Transplant (52)
  2. Center for Hematologic Malignancies (52)
  3. Department of Medicine (52)
  4. Executive Committee, Center for Hematologic Malignancies (52)
  5. GSK Faculty (52)
  6. Hematologic Malignancies, Division of (52)

More Groups

People
  1. Sergio Giralt (52)
  2. Marcel Van Den Brink (48)
  3. Miguel-Angel Perales (42)
  4. Juliet Barker (34)
  5. Doris Ponce (33)
  6. Esperanza Papadopoulos (29)

More People

Years
  1. 2023 (1)
  2. 2022 (1)
  3. 2021 (3)
  4. 2020 (3)
  5. 2019 (10)
  6. 2018 (7)

More Years

Publications
  1. Biology of Blood and Marrow Transplantation (47)
  2. Clinical Lymphoma, Myeloma and Leukemia (4)
  3. Transplantation and Cellular Therapy (1)

Results (52)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • A whole foods plant-based weight loss intervention improves metabolic and immune biomarkers in MGUS/SMM patients as well as progression trajectory in a subset: The NUTRIVENTION trial
    Meeting Abstract

    Shah, U.; Derkach, A.; Castro, F.; Anuraj, A.; Blaslov, J.; Hosszu, K.; Pollak, M.; Mailankody, S.; Korde, N.; Tan, C. R.; more...
    Clinical Lymphoma, Myeloma and Leukemia (2023)

    Fulltext@MSK | Save
  • A pilot plant based dietary intervention in MGUS and SMM is feasible and associated with reduction in insulin and leptin levels
    Meeting Abstract

    Shah, U.; Castro, F.; Anuraj, A.; Blaslov, J.; Adintori, P.; Derkach, A.; Pollak, M.; Maclachlan, K.; Mailankody, S.; Korde, N.; more...
    Clinical Lymphoma, Myeloma and Leukemia (2022)

    Fulltext@MSK | Save
  • Providing nutritional guidance for patients with plasma cell disorders - A missed opportunity for hematologists and oncologists?
    Meeting Abstract

    Sweeney, N.; Malik, M.; Jafri, M.; Derkach, A.; Chmielewski, C.; Adintori, P.; Mailankody, S.; Korde, N.; Tan, C.; Hassoun, H.; more...
    Clinical Lymphoma, Myeloma and Leukemia (2021)

    Fulltext@MSK | Save
  • Sustained minimal residual disease negativity in multiple myeloma is impacted positively by stool butyrate and healthier plant forward diets
    Meeting Abstract

    Shah, U.; Derkach, A.; Adintori, P.; Cross, J.; Maclachlan, K.; Mailankody, S.; Korde, N.; Hultcrantz, M.; Hassoun, H.; Tan, C.; more...
    Clinical Lymphoma, Myeloma and Leukemia (2021)

    Fulltext@MSK | Save
  • Cellular therapy during COVID-19: Lessons learned and preparing for subsequent waves
    Journal Article

    Nawas, M. T.; Shah, G. L.; Feldman, D. R.; Ruiz, J. D.; Robilotti, E. V.; Aslam, A. A.; Dundas, M.; Kamboj, M.; Barker, J. N.; Cho, C.; more...
    Transplantation and Cellular Therapy (2021)

    Fulltext@MSK | Save
  • Host T-cells contribute to immune reconstitution and improved outcome in recipients of CD34 selected T-cell depleted allografts (TCD HCT) with full hematopoietic cell but persistent mixed T-cell chimerism
    Meeting Abstract

    O'Reilly, R. J.; Koehne, G.; Heller, G.; Boulad, F.; Castro-Malaspina, H.; Giralt, S. A.; Jakubowski, A. A.; Kernan, N. A.; Papadopoulos, E. B.; Perales, M.; more...
    Biology of Blood and Marrow Transplantation (2020)

    Fulltext@MSK | Save
  • Don't let the HCT-CI fool you: Similar outcomes with myeloablative CD34+ selected allo-HCT compared to unmodified RIC allo-HCT in patients with AML or MDS and high comorbidity scores
    Meeting Abstract

    Pennisi, M.; Cho, C.; Devlin, S. M.; Ruiz, J. D.; Maloy, M. A.; Tomas, A. A.; Castillo, N.; Lin, R. J.; Politikos, I.; Sanchez-Escamilla, M.; more...
    Biology of Blood and Marrow Transplantation (2020)

    Fulltext@MSK | Save
  • Outcomes of two chemotherapy-based preparatory regimens compared to tbi-based conditioning when used with CD34(+) selected T-cell depleted alloHCT for high risk hematologic malignancies: Prospective clinical trial NCT 01119066
    Meeting Abstract

    O'Reilly, R. J.; Koehne, G.; Boulad, F.; Heller, G.; Klein, E.; Barker, J. N.; Castro-Malaspina, H.; Curran, K. J.; Hsu, K. C.; Jakubowski, A. A.; more...
    Biology of Blood and Marrow Transplantation (2020)

    Fulltext@MSK | Save
  • Thirty day resource utilization after chimeric antigen receptor (CAR) T cell infusion for hematologic malignancies
    Meeting Abstract

    Shah, G. L.; Park, J.; Sauter, C. S.; Duck, E.; Halton, E.; Batlevi, C. W.; Palomba, M. L.; Younes, A.; Geyer, M. B.; Smith, E.; more...
    Biology of Blood and Marrow Transplantation (2019)

    Fulltext@MSK | Save
  • Comparison of double unit cord blood transplants (dCBT) with 8/8 HLA-allele matched related (MRD) or unrelated donor (MUD) T-cell depleted (TCD) transplants in adults with myeloid malignancies: Comparable progression-free survival (PFS)
    Meeting Abstract

    Politikos, I.; Cho, C.; Devlin, S. M.; Maloy, M. A.; Naputo, K.; O'Reilly, R. J.; Scaradavou, A.; Castro-Malaspina, H.; Dahi, P. B.; Gyurkocza, B.; more...
    Biology of Blood and Marrow Transplantation (2019)

    Fulltext@MSK | Save